Glycemic Targets in Diabetes Care: Emerging Clarity after Accord

about

Does Elevated Glucose Promote Atherosclerosis? Pros and Cons.

P2860

Q37083092-78AFDEF3-3CB9-4138-B197-06E906AB8E64

P2860

Glycemic Targets in Diabetes Care: Emerging Clarity after Accord

Item

http://www.wikidata.org/entity/Q26795380

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Glycemic Targets in Diabetes Care: Emerging Clarity after Accord

@ast

Glycemic Targets in Diabetes Care: Emerging Clarity after Accord

@en

Glycemic Targets in Diabetes Care: Emerging Clarity after Accord

@nl

type

Item

label

Glycemic Targets in Diabetes Care: Emerging Clarity after Accord

@ast

Glycemic Targets in Diabetes Care: Emerging Clarity after Accord

@en

Glycemic Targets in Diabetes Care: Emerging Clarity after Accord

@nl

prefLabel

Glycemic Targets in Diabetes Care: Emerging Clarity after Accord

@ast

Glycemic Targets in Diabetes Care: Emerging Clarity after Accord

@en

Glycemic Targets in Diabetes Care: Emerging Clarity after Accord

@nl

P1476

Glycemic Targets in Diabetes Care: Emerging Clarity after Accord

@en

P2093

John B Buse

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Type 1 diabetes through the life span: a position statement of the American Diabetes Association

American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Effects of intensive glucose lowering in type 2 diabetes

10-year follow-up of intensive glucose control in type 2 diabetes

P304

62-76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P478

126

http://www.w3.org/2001/XMLSchema#string

P50

John Buse

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26330660

http://www.w3.org/2001/XMLSchema#string

P932

4530694

http://www.w3.org/2001/XMLSchema#string

Glycemic Targets in Diabetes Care: Emerging Clarity after Accord

about

P2860

P2860

Glycemic Targets in Diabetes Care: Emerging Clarity after Accord

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P407

P478

P50

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P407

P478

P50

P577

P698

P932